US Patent Issued to University of Pittsburgh-Of the Commonwealth System of Higher Education on Aug. 11 for "Focal adhesion kinase inhibitor as a therapeutic agent in diabetes" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,667, issued on Aug. 11, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh).

"Focal adhesion kinase inhibitor as a therapeutic agent in diabetes" was invented by Farzad Esni (Pittsburgh) and Jing Hu (Pittsburgh).

According to the abstract* released by the U.S. Patent & Trademark Office: "It is disclosed herein that a FAK inhibitor induces conversion of acinar cells into beta cells. Methods are provided for increasing beta cell proliferation by administering an effective amount of a FAK inhibitor to a subject in need thereof. Methods are also provided for treating a subject with diabetes or at risk of developing diabetes, comprising...